ACG: Compliance Reduces Inhospital Stay in Crohn’s (CME/CE)
SAN ANTONIO (MedPage Today) — Crohn’s disease patients who were more adherent to their prescribed injections of the anti-tumor necrosis factor infliximab spent less time in the hospital for disease flares than less adherent patients, researchers said here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com